Trexquant Investment’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-257,716
| Closed | -$1.89M | – | 1611 |
|
|
2024
Q1 | $1.89M | Buy |
+257,716
| New | +$1.89M | 0.04% | 678 |
|
|
2023
Q3 | – | Sell |
-333,986
| Closed | -$1.59M | – | 1564 |
|
|
2023
Q2 | $1.59M | Sell |
333,986
-31,400
| -9% | -$149K | 0.04% | 583 |
|
|
2023
Q1 | $2.08M | Buy |
365,386
+173,449
| +90% | +$989K | 0.06% | 445 |
|
|
2022
Q4 | $1.94M | Buy |
191,937
+129,049
| +205% | +$1.3M | 0.05% | 418 |
|
|
2022
Q3 | $1.41M | Buy |
62,888
+54,168
| +621% | +$1.21M | 0.05% | 436 |
|
|
2022
Q2 | $216K | Buy |
+8,720
| New | +$216K | 0.01% | 1313 |
|
|
2021
Q4 | – | Sell |
-15,428
| Closed | -$914K | – | 1395 |
|
|
2021
Q3 | $914K | Buy |
+15,428
| New | +$914K | 0.07% | 345 |
|
|
2021
Q2 | – | Sell |
-13,516
| Closed | -$1.11M | – | 1212 |
|
|
2021
Q1 | $1.11M | Buy |
13,516
+2,461
| +22% | +$203K | 0.1% | 251 |
|
|
2020
Q4 | $1.01M | Buy |
+11,055
| New | +$1.01M | 0.11% | 256 |
|
|
2020
Q1 | – | Sell |
-33,373
| Closed | -$653K | – | 1208 |
|
|
2019
Q4 | $653K | Buy |
+33,373
| New | +$653K | 0.04% | 484 |
|
|
2018
Q2 | – | Sell |
-18,369
| Closed | -$179K | – | 980 |
|
|
2018
Q1 | $179K | Buy |
+18,369
| New | +$179K | 0.01% | 963 |
|